50 Participants Needed

Neurofeedback for Obesity

KA
Overseen ByKathleen A Garrison, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether individuals with a high craving for food and obesity can alter their brain's response to food cues through neurofeedback. Neurofeedback is a technique that shows how the brain responds to certain stimuli and helps individuals learn to control it. Participants in this study will undergo sessions using Craving Network Neurofeedback, receiving either real or sham (fake) feedback, to determine its effect on cravings and eating habits. Individuals who have struggled with obesity, have a BMI over 25, and frequently crave food might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research on obesity and cravings.

Will I have to stop taking my current medications?

The trial requires that you do not use anti-obesity medications. If you are taking these, you would need to stop before participating.

What prior data suggests that this neurofeedback technique is safe for individuals with obesity?

Research on neurofeedback, including studies on eating habits and obesity, suggests it is generally safe. Participants in these studies did not report any serious side effects. For example, one study found that people using neurofeedback experienced a significant decrease in binge eating episodes, with no major safety concerns.

Another study tested infraslow neurofeedback, a similar method, and participants did not report any severe unwanted effects.

Although this trial is labeled as "Not Applicable" for its phase, existing research on neurofeedback for obesity provides insight into its safety. It appears well-tolerated by participants, with no major safety issues reported in past studies.12345

Why are researchers excited about this trial?

Researchers are excited about Craving Network Neurofeedback for obesity because it offers a novel approach by using real-time brain imaging to help individuals regulate their cravings. Unlike traditional treatments such as diet, exercise, or medication, this method involves participants seeing their brain activity through fMRI and learning to control areas associated with cravings. This technique could empower individuals to directly influence their brain's response to food cues, potentially leading to more sustainable weight management.

What evidence suggests that neurofeedback is effective for obesity?

This trial will compare Craving Network Neurofeedback with a control neurofeedback approach. Studies have shown that neurofeedback training can help people with obesity make healthier food choices by strengthening the connection between brain areas involved in cravings. One study found that neurofeedback sessions led to significant weight loss and better self-control, with participants also improving their eating habits. These findings suggest that neurofeedback could be a promising tool for managing obesity by changing how the brain responds to food signals.12346

Who Is on the Research Team?

KA

Kathleen A Garrison, PhD

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for adults aged 18 to 60 who are overweight or obese, with a body mass index (BMI) over 25 and experience strong food cravings as indicated by scoring more than 2.37 on the Food Craving Inventory.

Inclusion Criteria

My food craving score is above 2.37.
My BMI is over 25.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Neurofeedback Treatment

Participants undergo three imaging (fMRI) sessions of experimental or sham neurofeedback

3 weeks
3 visits (in-person)

Follow-up

Participants are monitored for changes in craving network strength and eating behavior

4 weeks
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Craving Network Neurofeedback
Trial Overview The study is examining if people with high food cravings can use neurofeedback to alter their brain's response to food cues, which may affect their desire for food and eating habits.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: NeurofeedbackExperimental Treatment1 Intervention
Group II: Control neurofeedbackPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Published Research Related to This Trial

In a study involving 21 obese women with food addiction symptoms, infraslow neurofeedback (ISF-NF) significantly increased brain activity in the posterior cingulate cortex (PCC) and reduced food craving after six sessions over three weeks, with no reported adverse effects.
The results indicate that ISF-NF may be a promising therapeutic approach for managing food cravings in individuals with obesity, as it led to measurable changes in brain activity and a decrease in craving levels compared to a placebo.
A randomised, double-blind, placebo-controlled parallel trial of closed-loop infraslow brain training in food addiction.Leong, SL., Vanneste, S., Lim, J., et al.[2023]
In a pilot study of 34 overweight and obese children, neurofeedback training did not lead to greater weight loss compared to standard lifestyle recommendations, with the intervention group showing a smaller reduction in body mass index after 6 months.
Despite less weight loss, children receiving neurofeedback reported improvements in eating behaviors, attention, hyperactivity, and sleep patterns, suggesting potential benefits beyond weight management that warrant further investigation.
Outcomes of neurofeedback training in childhood obesity management: a pilot study.Chirita-Emandi, A., Puiu, M.[2015]
A systematic review of 13 studies suggests that biofeedback and neurofeedback techniques may be beneficial in treating dysfunctional eating behaviors, such as food cravings and rumination, although they have not shown significant effects on body image disturbance.
These feedback-based techniques appear to modify both the body's sympathetic response to food-related stimuli and brain activity in reward-related areas, indicating a potential mechanism for their effectiveness in addressing certain eating disorder symptoms.
Feedback-Based Treatments for Eating Disorders and Related Symptoms: A Systematic Review of the Literature.Imperatori, C., Mancini, M., Della Marca, G., et al.[2019]

Citations

Neurofeedback for ObesityResearch shows that neurofeedback training can help people with obesity improve self-control over food choices by increasing the connection between brain areas ...
NCT06426693 | Craving Network NeurofeedbackTypes of outcome measures include primary outcome measure and secondary outcome measure. ... A type of intervention model describing a clinical trial in which two ...
Craving Network Neurofeedback | Clinical Research Trial ...This project tests whether individuals with overweight or obesity and high craving can learn to change their brain response to food cues ...
Evaluating the Efficacy of Neurofeedback in Post-Bariatric ...Significant reductions were also found in BUT subscales including Weight Phobia (p = 0.041, d = 0.84), Body Image Concern (p = 0.039, d = 0.90), ...
A pilot study of a novel therapeutic approach to obesityneurofeedback sessions produced a statistically significant weight loss, a trend of behavioral improvement in external eating and self-control and enhanced ...
A randomised, double-blind, placebo-controlled parallel ...This randomised, double-blind, placebo-controlled parallel study explored the potential therapeutic effects of infraslow neurofeedback (ISF-NF) on food craving.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security